SCHEMBL27769014

SCHEMBL27769014

C[C](C)CN1CCC(CN(C)c2cc(NCCOc3ccccc3Cl)ncn2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LCK P06239 1/20 0.35
RAB9A P51151 3/20 0.34
HSD17B10 Q99714 2/20 0.34
TSHR P16473 2/20 0.34
CYP1A2 P05177 1/20 0.34
ALOX15 P16050 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
ACACB O00763 2/20 0.33
NPC1 O15118 2/20 0.33
KCNA5 P22460 1/20 0.33
PKM P14618 1/20 0.33
DRD2 P14416 3/20 0.33
DRD4 P21917 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL386962 0.83 HTR6 (0.44) KDM4ELCKPKM
SCHEMBL4719132 0.82 LCK (0.36) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL386817 0.73 HTR6 (0.44) KDM4EPKM
SCHEMBL4719868 0.72 SSTR4 (0.35) KMT2ARAB9AACACBDRD2
SCHEMBL389866 0.65 GPR119 (0.46) MEN1KMT2AKDM4EPKMMAPT
SCHEMBL27734789 0.64 EGFR (0.43) LCK
SCHEMBL4721775 0.64 GPR119 (0.39) ACACB
SCHEMBL27951655 0.63 TBK1 (0.38) SMN1; SMN2CYP1A2CYP2C19ACACBCYP2D6
SCHEMBL390308 0.62 TBK1 (0.46) LCK
SCHEMBL386386 0.62 TBK1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101420941-A Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, and related combination therapies ARENA PHARM INC (US) 2009-04-29 CN disclosed